Mantegazza, R., O'Brien, F. L., Yountz, M., Howard, J. F., Gabriel Mazia, C., Wilken, M., Barroso, F., Saba, J., Rugiero, M., Bettini, M., Chaves, M., Vidal, G., Dalila Garcia, A., De Bleecker, J., Van den Abeele, G., de Koning, K., De Mey, K., Mercelis, R., Mahieu, D.
... Maeda, Y. (2020).
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Annals of Clinical and Translational Neurology,
7(8), 1327-1339.
https://doi.org/10.1002/acn3.51121GomezMancilla, B., Meriggioli, M. N., Genge, A., Roubenoff, R., Espié, P., Dupuy, C., Hartmann, N., Pezous, N., Kinhikar, A., Tichy, M., Dionne, A., Vissing, J.
, Andersen, H., Schoser, B., Meisel, A., Jordan, B., Devlikamova, F., Poverennova, I., Stuchevskaya, F. ... Gergely, P. (2024).
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study.
Journal of Clinical Neuroscience,
119, 76-84.
https://doi.org/10.1016/j.jocn.2023.11.013